Skip to main content
. 2017 Apr 17;12(4):e0175538. doi: 10.1371/journal.pone.0175538

Fig 1. Systematic review flowchart.

Fig 1

Thirteen studies addressing the prevalence of anti-KIR4.1 antibodies in MS and controls were identified. These 13 studies plus our own results were used for the systematic review.